Über 5 Jahre hinaus verlängerte endokrine Therapie

Davies, C; Pan, H; Godwin, J; Gray, R; Arriagada, R; Raina, V; Abraham, M; Medeiros Alencar, VH; Badran, A; Bonfill, X; Bradbury, J; Clarke, M; Collins, R; Davis, SR; Delmestri, A; Forbes, JF; Haddad, P; Hou, MF; Inbar, M; Khaled, H; Kielanowska, J; Kwan, WH; Mathew, BS; Mittra, I; Muller, B; Nicolu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Onkologie (Heidelberg, Germany) Germany), 2017-07, Vol.23 (7), p.573-574
1. Verfasser: Witzel, Isabell
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Davies, C; Pan, H; Godwin, J; Gray, R; Arriagada, R; Raina, V; Abraham, M; Medeiros Alencar, VH; Badran, A; Bonfill, X; Bradbury, J; Clarke, M; Collins, R; Davis, SR; Delmestri, A; Forbes, JF; Haddad, P; Hou, MF; Inbar, M; Khaled, H; Kielanowska, J; Kwan, WH; Mathew, BS; Mittra, I; Muller, B; Nicolucci, A; Peralta, O; Pernas, F; Petruzelka, L; Pienkowski, T; Radhika, R; Rajan, B; Rubach, MT; Tort, S; Urrutia, G; Valentini, M; Wang, Y; Peto, R Adjuvant Tamoxifen: Longer Against Shorter Collaborative G. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Mamounas EP, Bandos H, Lembersky BC, Geyer CE Jr, Fehrenbacher L, Graham ML, Chia SL, Brufsky AM, Hennessy BT, Soori GS, Dakil SR, Seay TE, Wade JL III, McCarron EC, Paik S, Swain SM, Wickerham DL, Wolmark N (2016) A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B‑42. Tjan-Heijnen, VC; Van Hellemond, IE; Peer, PG; Swinkels, AC; Smorenburg, CH; Van der Sangen, M; Kroep, JR; DeGraaf, H; Honkoop, AH; Erdkamp, F; Van den Berkmortel, FW; Kitzen, JJ; De Boer, M; De Roos, WK; Linn, SC; Imholz, AL; Seynaeve, C. First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2–3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer; 2016; pp. 1-3.
ISSN:2731-7226
2731-7234
DOI:10.1007/s00761-017-0242-6